CorMedix (CRMD) News Today $12.28 +0.59 (+5.05%) Closing price 04:00 PM EasternExtended Trading$12.09 -0.19 (-1.55%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRMD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period CorMedix Inc. to Participate in the RBC Global Healthcare ConferenceMay 15 at 8:30 AM | globenewswire.comJ. Goldman & Co LP Boosts Stake in CorMedix Inc. (NASDAQ:CRMD)J. Goldman & Co LP boosted its stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 221.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 457,320 shares of the company's stock after buying aMay 14 at 5:59 AM | marketbeat.comWhat is Leerink Partnrs' Estimate for CorMedix Q2 Earnings?CorMedix Inc. (NASDAQ:CRMD - Free Report) - Research analysts at Leerink Partnrs upped their Q2 2025 earnings per share estimates for CorMedix in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will earn $0.14 per share for the quarter,May 11, 2025 | marketbeat.comElliott Investment Management L.P. Buys 1,320,109 Shares of CorMedix Inc. (NASDAQ:CRMD)Elliott Investment Management L.P. lifted its stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 85.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,870,632 shares of theMay 11, 2025 | marketbeat.comQ2 Earnings Estimate for CorMedix Issued By Leerink PartnrsMay 11, 2025 | americanbankingnews.comWhat is Leerink Partnrs' Forecast for CorMedix Q3 Earnings?CorMedix Inc. (NASDAQ:CRMD - Free Report) - Leerink Partnrs reduced their Q3 2025 earnings estimates for CorMedix in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst R. Ruiz now expects that the company will earn $0.13 per share for the quarter, down from their previous forecasMay 10, 2025 | marketbeat.comCorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 10, 2025 | finance.yahoo.comQ3 Earnings Forecast for CorMedix Issued By Leerink PartnrsMay 10, 2025 | americanbankingnews.comNeedham & Company LLC Issues Positive Forecast for CorMedix (NASDAQ:CRMD) Stock PriceNeedham & Company LLC increased their target price on CorMedix from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday.May 9, 2025 | marketbeat.comCorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 9, 2025 | insidermonkey.comBarclays PLC Purchases 27,732 Shares of CorMedix Inc. (NASDAQ:CRMD)Barclays PLC raised its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 35.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 105,602 shares of the company's stock after purchasingMay 9, 2025 | marketbeat.comAnalysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) EstimatesMay 8, 2025 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call TranscriptMay 8, 2025 | insidermonkey.comCorMedix (NASDAQ:CRMD) Receives Buy Rating from D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and set a $15.00 price objective on shares of CorMedix in a research note on Tuesday.May 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Releases Quarterly Earnings ResultsCorMedix (NASDAQ:CRMD - Get Free Report) issued its earnings results on Tuesday. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.25 by $0.05. During the same period last year, the business posted ($0.25) earnings per share.May 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Shares Gap Up Following Better-Than-Expected EarningsCorMedix (NASDAQ:CRMD) Shares Gap Up After Earnings BeatMay 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Receives "Buy" Rating from D. Boral CapitalMay 8, 2025 | americanbankingnews.comRaymond James Financial Inc. Buys Shares of 115,661 CorMedix Inc. (NASDAQ:CRMD)Raymond James Financial Inc. bought a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 115,661 shares of the company's stock, valuMay 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Sees Strong Trading Volume After Earnings BeatMay 8, 2025 | americanbankingnews.comCorMedix (NASDAQ:CRMD) Shares Gap Up on Better-Than-Expected EarningsMay 8, 2025 | americanbankingnews.comEarnings call transcript: CorMedix Q1 2025 results beat expectations, stock risesMay 7, 2025 | uk.investing.comCorMedix Inc. Reports Q1 2025 Financial Results: $39.1 Million in Net Revenue and Positive Adjusted EBITDA of $23.6 MillionMay 7, 2025 | nasdaq.comCorMedix Inc.May 7, 2025 | wsj.comCormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 7, 2025 | finance.yahoo.comCormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ...May 7, 2025 | finance.yahoo.comCorMedix, Inc.: CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | finanznachrichten.deCorMedix stock rises as Q1 earnings and revenue surpass estimatesMay 6, 2025 | investing.comCorMedix Q1 Earnings Trump Estimates: Retail’s OverjoyedMay 6, 2025 | msn.comCorMedix stock rises after earnings, revenue beatMay 6, 2025 | msn.comCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update | CRMD ...May 6, 2025 | gurufocus.comCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | gurufocus.comCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | globenewswire.comRenaissance Technologies LLC Makes New $1.09 Million Investment in CorMedix Inc. (NASDAQ:CRMD)Renaissance Technologies LLC purchased a new stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 134,000 shares of the company'May 3, 2025 | marketbeat.comCorMedix (CRMD) Expected to Announce Earnings on TuesdayCorMedix (NASDAQ:CRMD) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-cormedix-inc-stock-1/)May 3, 2025 | marketbeat.comCorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025April 29, 2025 | globenewswire.comCorMedix Inc. (NASDAQ:CRMD) Receives Average Rating of "Buy" from BrokeragesShares of CorMedix Inc. (NASDAQ:CRMD - Get Free Report) have received an average rating of "Buy" from the seven research firms that are currently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has issued a strong buApril 28, 2025 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Holdings Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. increased its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 40.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 273,218 shares of the company's stock after purchasing an addApril 26, 2025 | marketbeat.comGeode Capital Management LLC Acquires 108,356 Shares of CorMedix Inc. (NASDAQ:CRMD)Geode Capital Management LLC increased its holdings in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,392,820 shares of the company's stock after buyinApril 25, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Stock Price Up 4.7% - Should You Buy?CorMedix (NASDAQ:CRMD) Stock Price Up 4.7% - Here's What HappenedApril 23, 2025 | marketbeat.comAdvisory Services Network LLC Purchases New Shares in CorMedix Inc. (NASDAQ:CRMD)Advisory Services Network LLC acquired a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 51,600 shares of the company's stock, valued atApril 19, 2025 | marketbeat.comInvestors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five yearsApril 17, 2025 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. lifted its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 10.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,378,191 shares of the company's stock after acquiring an additional 309,514 shares during the period. VaApril 16, 2025 | marketbeat.comCorMedix's (CRMD) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $12.00 price objective on shares of CorMedix in a research note on Wednesday.April 11, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Given Buy Rating at D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $15.00 target price on shares of CorMedix in a research report on Tuesday.April 10, 2025 | marketbeat.comCorMedix reports preliminary Q1 revenue $39M, consensus $32.2M.April 9, 2025 | markets.businessinsider.comRBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-termApril 8, 2025 | markets.businessinsider.comCorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s ElatedApril 8, 2025 | msn.comCorMedix, Inc.: Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales GuidanceApril 8, 2025 | finanznachrichten.deCorMedix Shares Gain After 1Q Preliminary Sales Beat ViewsApril 8, 2025 | marketwatch.comCormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales GuidanceApril 8, 2025 | globenewswire.com Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.980.79▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼114▲CRMD Articles Average Week Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRNX News SRRK News ALVO News MRUS News ACAD News CPRX News MTSR News MOR News PTGX News XENE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored“Market Wizard” signals rare opportunityThe Fed Is Losing Control — What Comes Next Will Shock Traders The Fed is stuck — rising inflation and risi...Brownstone Research | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored How much money will YOU make when gold hits $5,000?What if I told you there was a way to secure a shot at making asymmetric gains from gold’s current historic bu...Eagle Publishing | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRMD Stock Free CRMD Stock Alerts